Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile
Status: SUSPENDED
Study type: OBSERVATIONAL
Conditions: Metastatic Triple-Negative Breast Cancer
Sponsor: Texas Tech University Health Sciences Center, El Paso